Triple
T4850505
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Heptares Therapeutics |
E108401
|
entity |
| Predicate | collaboratesWith |
P37
|
FINISHED |
| Object |
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
|
E474950
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Takeda Pharmaceutical Company | Statement: [Heptares Therapeutics, collaboratesWith, Takeda Pharmaceutical Company]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Takeda Pharmaceutical Company Context triple: [Heptares Therapeutics, collaboratesWith, Takeda Pharmaceutical Company]
-
A.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
B.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
C.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
-
D.
Sankyo Company
Sankyo Company is a Japanese pharmaceutical firm known for its role in developing cholesterol-lowering statin drugs and later becoming part of Daiichi Sankyo.
-
E.
Sumitomo Corporation
Sumitomo Corporation is a major Japanese multinational trading and investment company and one of the core members of the Sumitomo Group conglomerate.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Takeda Pharmaceutical Company Triple: [Heptares Therapeutics, collaboratesWith, Takeda Pharmaceutical Company]
Generated description
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Takeda Pharmaceutical Company Target entity description: Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
A.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
B.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
C.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
-
D.
Sankyo Company
Sankyo Company is a Japanese pharmaceutical firm known for its role in developing cholesterol-lowering statin drugs and later becoming part of Daiichi Sankyo.
-
E.
Sumitomo Corporation
Sumitomo Corporation is a major Japanese multinational trading and investment company and one of the core members of the Sumitomo Group conglomerate.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd440a89548190a5f14ba6da6b97dc |
completed | March 20, 2026, 12:56 p.m. |
| NER | Named-entity recognition | batch_69bd6d1e5cf08190bd6b6a524748f170 |
completed | March 20, 2026, 3:51 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69be5cdefda8819095fbc04446bf32f5 |
completed | March 21, 2026, 8:54 a.m. |
| NEDg | Description generation | batch_69be5dadcec88190bf9a272c4a9aef9a |
completed | March 21, 2026, 8:58 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69be6159ff7c8190baa116240f76dea5 |
completed | March 21, 2026, 9:14 a.m. |
Created at: March 20, 2026, 1:25 p.m.